A Phase 4, Open-Label, Non-Randomized, Multicenter Study to Evaluate Efficacy (and Safety) of Intravenous Administration of Optison for Contrast-Enhanced Echocardiography in Pediatric Patients.

Saved in:
Bibliographic Details
Title: A Phase 4, Open-Label, Non-Randomized, Multicenter Study to Evaluate Efficacy (and Safety) of Intravenous Administration of Optison for Contrast-Enhanced Echocardiography in Pediatric Patients.
Authors: Sabati A; Division of Cardiology, Center for Heart Care, Phoenix Children's Hospital, 1919 E Thomas Road, Phoenix, AZ, 85016, USA. asabati@phoenixchildrens.com., Wang S; Children's Hospital Los Angeles, Los Angeles, CA, USA., Shivaram P; Medical College of Georgia, Augusta, GA, USA., Hawley J; GE Healthcare, Buckinghamshire, UK., Thompson D; GE Healthcare, Buckinghamshire, UK., Erenberg F; Cleveland Clinic Lerner College of Medicine, Cleveland, OH, USA., Kutty S; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Kulkarni A; Northwell Health, Cohen Children's Medical Center, Heart Center, New Hyde Park, NY, USA., Doan TT; Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA., Robinson JD; Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, IL, USA.
Source: Pediatric cardiology [Pediatr Cardiol] 2026 Jun; Vol. 47 (5), pp. 2052-2066. Date of Electronic Publication: 2025 Aug 27.
Publication Type: Journal Article; Multicenter Study; Clinical Trial, Phase IV
Journal Info: Publisher: Springer Verlag Country of Publication: United States NLM ID: 8003849 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1971 (Electronic) Linking ISSN: 01720643 NLM ISO Abbreviation: Pediatr Cardiol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1432-1971
DOI:10.1007/s00246-025-03993-4